NDC properties for NDC 9 0591-2422
NDC item 00591242212
| NDC 9 | 0591-2422 |
|---|---|
| NDC 10 | 0591-2422-12 |
| NDC Item | 00591242212 |
| packaging | 1 BOTTLE, DROPPER in 1 CARTON (0591-2422-12) / 15 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA201949 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-11-30 |
| Marketing effective time low | 2022-10-07 |
| Marketing status | COMPLETED |
NDC item 00591242226
| NDC 9 | 0591-2422 |
|---|---|
| NDC 10 | 0591-2422-26 |
| NDC Item | 00591242226 |
| packaging | 1 BOTTLE, DROPPER in 1 CARTON (0591-2422-26) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA201949 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-11-30 |
| Marketing effective time low | 2022-10-07 |
| Marketing status | COMPLETED |
NDC item 00591242279
| NDC 9 | 0591-2422 |
|---|---|
| NDC 10 | 0591-2422-79 |
| NDC Item | 00591242279 |
| packaging | 1 BOTTLE, DROPPER in 1 CARTON (0591-2422-79) / 10 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA201949 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-11-30 |
| Marketing effective time low | 2022-10-07 |
| Marketing status | COMPLETED |
NDC item 00781718670
| NDC 9 | 0781-7186 |
|---|---|
| NDC 10 | 0781-7186-70 |
| NDC Item | 00781718670 |
| packaging | 10 mL in 1 BOTTLE, DROPPER (0781-7186-70) |
| ANDA | ANDA091087 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-04-13 |
| Marketing status | ACTIVE |
NDC item 00781718675
| NDC 9 | 0781-7186 |
|---|---|
| NDC 10 | 0781-7186-75 |
| NDC Item | 00781718675 |
| packaging | 5 mL in 1 BOTTLE, DROPPER (0781-7186-75) |
| ANDA | ANDA091087 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-04-13 |
| Marketing status | ACTIVE |
NDC item 00781718685
| NDC 9 | 0781-7186 |
|---|---|
| NDC 10 | 0781-7186-85 |
| NDC Item | 00781718685 |
| packaging | 15 mL in 1 BOTTLE, DROPPER (0781-7186-85) |
| ANDA | ANDA091087 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-04-13 |
| Marketing status | ACTIVE |
NDC item 00832142505
| NDC 9 | 0832-1425 |
|---|---|
| NDC 10 | 0832-1425-05 |
| NDC Item | 00832142505 |
| packaging | 1 BOTTLE, DROPPER in 1 CARTON (0832-1425-05) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA215598 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-12-15 |
| Marketing status | ACTIVE |
NDC item 00832142510
| NDC 9 | 0832-1425 |
|---|---|
| NDC 10 | 0832-1425-10 |
| NDC Item | 00832142510 |
| packaging | 1 BOTTLE, DROPPER in 1 CARTON (0832-1425-10) / 10 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA215598 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-12-15 |
| Marketing status | ACTIVE |
NDC item 00832142515
| NDC 9 | 0832-1425 |
|---|---|
| NDC 10 | 0832-1425-15 |
| NDC Item | 00832142515 |
| packaging | 1 BOTTLE, DROPPER in 1 CARTON (0832-1425-15) / 15 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA215598 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-12-15 |
| Marketing status | ACTIVE |
NDC item 46708070605
| NDC 9 | 46708-706 |
|---|---|
| NDC 10 | 46708-706-05 |
| NDC Item | 46708070605 |
| packaging | 1 BOTTLE, DROPPER in 1 CARTON (46708-706-05) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA215230 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-08-25 |
| Marketing status | ACTIVE |
NDC item 46708070610
| NDC 9 | 46708-706 |
|---|---|
| NDC 10 | 46708-706-10 |
| NDC Item | 46708070610 |
| packaging | 1 BOTTLE, DROPPER in 1 CARTON (46708-706-10) / 10 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA215230 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-08-25 |
| Marketing status | ACTIVE |
NDC item 46708070615
| NDC 9 | 46708-706 |
|---|---|
| NDC 10 | 46708-706-15 |
| NDC Item | 46708070615 |
| packaging | 1 BOTTLE, DROPPER in 1 CARTON (46708-706-15) / 15 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA215230 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-08-25 |
| Marketing status | ACTIVE |
NDC item 60219206703
| NDC 9 | 60219-2067 |
|---|---|
| NDC 10 | 60219-2067-3 |
| NDC Item | 60219206703 |
| packaging | 1 BOTTLE in 1 CARTON (60219-2067-3) / 5 mL in 1 BOTTLE |
| ANDA | ANDA217288 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-01-02 |
| Marketing status | ACTIVE |
NDC item 60219206806
| NDC 9 | 60219-2068 |
|---|---|
| NDC 10 | 60219-2068-6 |
| NDC Item | 60219206806 |
| packaging | 1 BOTTLE in 1 CARTON (60219-2068-6) / 10 mL in 1 BOTTLE |
| ANDA | ANDA217288 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-01-02 |
| Marketing status | ACTIVE |
NDC item 60219213808
| NDC 9 | 60219-2138 |
|---|---|
| NDC 10 | 60219-2138-8 |
| NDC Item | 60219213808 |
| packaging | 1 BOTTLE in 1 CARTON (60219-2138-8) / 15 mL in 1 BOTTLE |
| ANDA | ANDA217288 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-01-02 |
| Marketing status | ACTIVE |
NDC item 60505058901
| NDC 9 | 60505-0589 |
|---|---|
| NDC 10 | 60505-0589-1 |
| NDC Item | 60505058901 |
| packaging | 1 BOTTLE, DROPPER in 1 CARTON (60505-0589-1) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA091442 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-10-19 |
| Marketing status | ACTIVE |
NDC item 60505058902
| NDC 9 | 60505-0589 |
|---|---|
| NDC 10 | 60505-0589-2 |
| NDC Item | 60505058902 |
| packaging | 1 BOTTLE, DROPPER in 1 CARTON (60505-0589-2) / 10 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA091442 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-10-19 |
| Marketing status | ACTIVE |
NDC item 60505058903
| NDC 9 | 60505-0589 |
|---|---|
| NDC 10 | 60505-0589-3 |
| NDC Item | 60505058903 |
| packaging | 1 BOTTLE, DROPPER in 1 CARTON (60505-0589-3) / 15 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA091442 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-10-19 |
| Marketing status | ACTIVE |
NDC item 60505622500
| NDC 9 | 60505-6225 |
|---|---|
| NDC 10 | 60505-6225-0 |
| NDC Item | 60505622500 |
| packaging | 1 BOTTLE, DROPPER in 1 CARTON (60505-6225-0) / 5 mL in 1 BOTTLE, DROPPER |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time high | 2024-12-31 |
| Marketing effective time low | 2022-01-19 |
| Marketing status | COMPLETED |
| NDA_AUTHORIZED_GENERIC | NDA021398 |
NDC item 60505622501
| NDC 9 | 60505-6225 |
|---|---|
| NDC 10 | 60505-6225-1 |
| NDC Item | 60505622501 |
| packaging | 1 BOTTLE, DROPPER in 1 CARTON (60505-6225-1) / 10 mL in 1 BOTTLE, DROPPER |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time high | 2024-12-31 |
| Marketing effective time low | 2022-01-19 |
| Marketing status | COMPLETED |
| NDA_AUTHORIZED_GENERIC | NDA021398 |
NDC item 60505622502
| NDC 9 | 60505-6225 |
|---|---|
| NDC 10 | 60505-6225-2 |
| NDC Item | 60505622502 |
| packaging | 1 BOTTLE, DROPPER in 1 CARTON (60505-6225-2) / 15 mL in 1 BOTTLE, DROPPER |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time high | 2024-12-31 |
| Marketing effective time low | 2022-01-19 |
| Marketing status | COMPLETED |
| NDA_AUTHORIZED_GENERIC | NDA021398 |
NDC item 62332070605
| NDC 9 | 62332-706 |
|---|---|
| NDC 10 | 62332-706-05 |
| NDC Item | 62332070605 |
| packaging | 1 BOTTLE, DROPPER in 1 CARTON (62332-706-05) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA215230 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-08-25 |
| Marketing status | ACTIVE |
NDC item 62332070610
| NDC 9 | 62332-706 |
|---|---|
| NDC 10 | 62332-706-10 |
| NDC Item | 62332070610 |
| packaging | 1 BOTTLE, DROPPER in 1 CARTON (62332-706-10) / 10 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA215230 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-08-25 |
| Marketing status | ACTIVE |
NDC item 62332070615
| NDC 9 | 62332-706 |
|---|---|
| NDC 10 | 62332-706-15 |
| NDC Item | 62332070615 |
| packaging | 1 BOTTLE, DROPPER in 1 CARTON (62332-706-15) / 15 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA215230 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-08-25 |
| Marketing status | ACTIVE |
NDC item 65145016201
| NDC 9 | 65145-162 |
|---|---|
| NDC 10 | 65145-162-01 |
| NDC Item | 65145016201 |
| packaging | 1 BOTTLE, DROPPER in 1 CARTON (65145-162-01) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA219093 |
| Labeler | Caplin Steriles Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-03-10 |
| Marketing status | ACTIVE |
NDC item 65145016301
| NDC 9 | 65145-163 |
|---|---|
| NDC 10 | 65145-163-01 |
| NDC Item | 65145016301 |
| packaging | 1 BOTTLE, DROPPER in 1 CARTON (65145-163-01) / 10 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA219093 |
| Labeler | Caplin Steriles Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-03-10 |
| Marketing status | ACTIVE |
NDC item 65145016401
| NDC 9 | 65145-164 |
|---|---|
| NDC 10 | 65145-164-01 |
| NDC Item | 65145016401 |
| packaging | 1 BOTTLE, DROPPER in 1 CARTON (65145-164-01) / 15 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA219093 |
| Labeler | Caplin Steriles Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-03-10 |
| Marketing status | ACTIVE |
NDC item 68462028132
| NDC 9 | 68462-281 |
|---|---|
| NDC 10 | 68462-281-32 |
| NDC Item | 68462028132 |
| packaging | 1 BOTTLE, DROPPER in 1 CARTON (68462-281-32) / 10 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA214987 |
| Labeler | Glenmark Pharmaceuticals Inc., USA |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-16 |
| Marketing status | ACTIVE |
NDC item 68462028169
| NDC 9 | 68462-281 |
|---|---|
| NDC 10 | 68462-281-69 |
| NDC Item | 68462028169 |
| packaging | 1 BOTTLE, DROPPER in 1 CARTON (68462-281-69) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA214987 |
| Labeler | Glenmark Pharmaceuticals Inc., USA |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-16 |
| Marketing status | ACTIVE |
NDC item 69315033005
| NDC 9 | 69315-330 |
|---|---|
| NDC 10 | 69315-330-05 |
| NDC Item | 69315033005 |
| packaging | 1 BOTTLE, DROPPER in 1 CARTON (69315-330-05) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA219093 |
| Labeler | Leading Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-05-29 |
| Marketing status | ACTIVE |
NDC item 69315033010
| NDC 9 | 69315-330 |
|---|---|
| NDC 10 | 69315-330-10 |
| NDC Item | 69315033010 |
| packaging | 1 BOTTLE, DROPPER in 1 CARTON (69315-330-10) / 10 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA219093 |
| Labeler | Leading Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-05-29 |
| Marketing status | ACTIVE |
NDC item 69315033015
| NDC 9 | 69315-330 |
|---|---|
| NDC 10 | 69315-330-15 |
| NDC Item | 69315033015 |
| packaging | 1 BOTTLE, DROPPER in 1 CARTON (69315-330-15) / 15 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA219093 |
| Labeler | Leading Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-05-29 |
| Marketing status | ACTIVE |
NDC item 70069065101
| NDC 9 | 70069-651 |
|---|---|
| NDC 10 | 70069-651-01 |
| NDC Item | 70069065101 |
| packaging | 1 BOTTLE in 1 CARTON (70069-651-01) / 5 mL in 1 BOTTLE |
| ANDA | ANDA216114 |
| Labeler | Somerset Therapeutics, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-10-10 |
| Marketing status | ACTIVE |
NDC item 70069065201
| NDC 9 | 70069-652 |
|---|---|
| NDC 10 | 70069-652-01 |
| NDC Item | 70069065201 |
| packaging | 1 BOTTLE in 1 CARTON (70069-652-01) / 10 mL in 1 BOTTLE |
| ANDA | ANDA216114 |
| Labeler | Somerset Therapeutics, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-10-10 |
| Marketing status | ACTIVE |
NDC item 70069065301
| NDC 9 | 70069-653 |
|---|---|
| NDC 10 | 70069-653-01 |
| NDC Item | 70069065301 |
| packaging | 1 BOTTLE in 1 CARTON (70069-653-01) / 15 mL in 1 BOTTLE |
| ANDA | ANDA216114 |
| Labeler | Somerset Therapeutics, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-10-10 |
| Marketing status | ACTIVE |
NDC item 71921018805
| NDC 9 | 71921-188 |
|---|---|
| NDC 10 | 71921-188-05 |
| NDC Item | 71921018805 |
| packaging | 1 BOTTLE, DROPPER in 1 CARTON (71921-188-05) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA201949 |
| Labeler | Florida Pharmaceutical Products, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-11-23 |
| Marketing status | ACTIVE |
NDC item 71921018810
| NDC 9 | 71921-188 |
|---|---|
| NDC 10 | 71921-188-10 |
| NDC Item | 71921018810 |
| packaging | 1 BOTTLE, DROPPER in 1 CARTON (71921-188-10) / 10 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA201949 |
| Labeler | Florida Pharmaceutical Products, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-11-23 |
| Marketing status | ACTIVE |
NDC item 71921018815
| NDC 9 | 71921-188 |
|---|---|
| NDC 10 | 71921-188-15 |
| NDC Item | 71921018815 |
| packaging | 1 BOTTLE, DROPPER in 1 CARTON (71921-188-15) / 15 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA201949 |
| Labeler | Florida Pharmaceutical Products, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-11-23 |
| Marketing status | ACTIVE |
NDC item 72162209602
| NDC 9 | 72162-2096 |
|---|---|
| NDC 10 | 72162-2096-2 |
| NDC Item | 72162209602 |
| packaging | 1 BOTTLE, DROPPER in 1 CARTON (72162-2096-2) / 10 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA091442 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-10-19 |
| Marketing status | ACTIVE |
NDC item 72162209604
| NDC 9 | 72162-2096 |
|---|---|
| NDC 10 | 72162-2096-4 |
| NDC Item | 72162209604 |
| packaging | 1 BOTTLE, DROPPER in 1 CARTON (72162-2096-4) / 15 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA091442 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-10-19 |
| Marketing status | ACTIVE |
NDC item 72162209607
| NDC 9 | 72162-2096 |
|---|---|
| NDC 10 | 72162-2096-7 |
| NDC Item | 72162209607 |
| packaging | 1 BOTTLE, DROPPER in 1 CARTON (72162-2096-7) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA091442 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-10-19 |
| Marketing status | ACTIVE |
NDC item 72485063405
| NDC 9 | 72485-634 |
|---|---|
| NDC 10 | 72485-634-05 |
| NDC Item | 72485063405 |
| packaging | 1 BOTTLE, DROPPER in 1 CARTON (72485-634-05) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA201949 |
| Labeler | ARMAS PHARMACEUTICALS INC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-11-03 |
| Marketing status | ACTIVE |
NDC item 72485063410
| NDC 9 | 72485-634 |
|---|---|
| NDC 10 | 72485-634-10 |
| NDC Item | 72485063410 |
| packaging | 1 BOTTLE, DROPPER in 1 CARTON (72485-634-10) / 10 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA201949 |
| Labeler | ARMAS PHARMACEUTICALS INC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-11-03 |
| Marketing status | ACTIVE |
NDC item 82182045505
| NDC 9 | 82182-455 |
|---|---|
| NDC 10 | 82182-455-05 |
| NDC Item | 82182045505 |
| packaging | 5 mL in 1 BOTTLE, PLASTIC (82182-455-05) |
| Labeler | Pacific Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2022-10-21 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA021398 |
NDC item 82182045510
| NDC 9 | 82182-455 |
|---|---|
| NDC 10 | 82182-455-10 |
| NDC Item | 82182045510 |
| packaging | 10 mL in 1 BOTTLE, PLASTIC (82182-455-10) |
| Labeler | Pacific Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2022-10-21 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA021398 |
NDC item 82182045515
| NDC 9 | 82182-455 |
|---|---|
| NDC 10 | 82182-455-15 |
| NDC Item | 82182045515 |
| packaging | 15 mL in 1 BOTTLE, PLASTIC (82182-455-15) |
| Labeler | Pacific Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2022-10-21 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA021398 |